Hatchtech Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HATCHTECH, and when can generic versions of HATCHTECH drugs launch?
HATCHTECH has one approved drug.
There are five US patents protecting HATCHTECH drugs.
There are thirty-three patent family members on HATCHTECH drugs in fifteen countries.
Summary for Hatchtech
| International Patents: | 33 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Hatchtech
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 10,292,389 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 9,357,783 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 9,839,631 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 8,212,038 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | DISCN | Yes | No | 7,812,163 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hatchtech
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | 8,212,038 | ⤷ Sign Up |
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | 9,839,631 | ⤷ Sign Up |
| Hatchtech | XEGLYZE | abametapir | LOTION;TOPICAL | 206966-001 | Jul 24, 2020 | 9,357,783 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Hatchtech Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 1822854 | ⤷ Sign Up |
| European Patent Office | 1845782 | ⤷ Sign Up |
| Denmark | 2457582 | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2015107384 | ⤷ Sign Up |
| Australia | 2004257351 | ⤷ Sign Up |
| New Zealand | 720995 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
